Anti-PD1 therapy
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Anti-PD1 therapy, covering 2020-05-19 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors [Phase 1, Phase 2]